UBS’s iShares Biotechnology ETF IBB Stock Holding History

UBS’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$335M	Buy	3,673,590 +333,306	+10%	+$29.3M	0.25%	78
2014 Q2	$286M	Sell	3,340,284 -67,515	-2%	-$5.32M	0.22%	96
2014 Q1	$269M	Buy	3,407,799 +1,365,348	+67%	+$114M	0.24%	83
2013 Q4	$155M	Buy	2,042,451 +7,839	+0.4%	+$556K	0.14%	154
2013 Q3	$142M	Buy	2,034,612 +148,749	+8%	+$9.75M	0.15%	155
2013 Q2	$109M	Buy	+1,885,863	New	+$109M	0.13%	161

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS's IBB Position: Q3 2014 in Review

UBS increased its iShares Biotechnology ETF (IBB) stake by 10% in Q3 2014, buying an estimated $29.3M and bringing the position to 3,673,590 shares worth $335M. The position accounts for 0.25% of the portfolio, ranked #78.

UBS first reported a position in IBB in Q2 2013 and has held it in 6 quarters since. 318 funds tracked by Wall St. Rank hold IBB as of Q3 2014.

UBS held 3,673,590 shares of iShares Biotechnology ETF worth $335M as of Q3 2014.
UBS bought 333,306 iShares Biotechnology ETF shares in Q3 2014, an estimated $29.3M.
iShares Biotechnology ETF made up 0.25% of UBS's portfolio in Q3 2014, its #78 holding.
UBS first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 6 quarters since.
318 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.